Clinical and <scp>MRI</scp> predictors of response to interferon‐beta and glatiramer acetate in relapsing–remitting multiple sclerosis patients

Abstract

A lower baseline MRI and clinical activity have been identified as predictors of DMT efficacy in patients with RRMS in routine clinical practice. Evaluation of clinical and MRI activity at 1 year is recommended to monitor patients over time.